This is the 36th year of this highly successful research training program in Rheumatology at the Massachusetts General Hospital (MGH), Harvard Medical School (HMS), supported by training grant T32 AR07258. The goal of this program is to train MD, MD/PhD and PhD post-doctoral fellows for independent investigative careers in rheumatology research. Of the 54 graduates of the program that were directly supported by this training grant, many now have faculty appointments in academic medical centers, including holding leadership positions at major institutions as Deans, Scientific Directors, and Division Chiefs. Our program centers on our highly successful clinical fellowship in Rheumatology and our strong basic, translational and clinical science programs situated in an exciting, vibrant and technologically innovative research environment. Our Rheumatology Training Program provides supervised laboratory and clinical research under the guidance of accomplished faculty members, as well as structured training in rheumatology, immunology, clinical trials, biostatistics and ethical issues through courses or conferences. The research focus of the program is the study of the immunopathogenesis of rheumatic disease. Areas of particular interest include autoimmunity, innate immunity, leukocyte trafficking, inflammation, infectious causes of rheumatic diseases, systems immunology, fibrosis, and stem cell biology. Disease areas of particular interest include rheumatoid arthritis, lupus, scleroderma, Lyme, vasculitis and IgG4-related disease. This application requests 4 training positions that will be allocated to trainees who are committed to at least 2 to 3 years of research training. The candidates will be drawn from the MGH Rheumatology fellowship and from post-doctoral trainees already in faculty mentor laboratories. Twelve faculty members primarily from the MGH Rheumatology Unit and its affiliated Center for Immunology &Inflammatory Diseases (CIID) participate in this Rheumatology Training Program and were carefully chosen based on their track record of publication, grants, mentoring, collaboration and a mutual interest in rheumatology and immunology. The training program also leverages many of the research centers at MGH, including the Centers Systems Biology, Cancer, Regenerative Medicine, and Cardiovascular Disease. The MGH provides an outstanding training environment with over 1400 investigators, thematic research centers, trainee support groups, and over $700 million in NIH research grant awards. Opportunities at Harvard University, including course work and the Harvard Clinical and Translational Science Center (a member of the NIH-funded Clinical and Translational Science Award Consortium) and the Broad Institute of MIT and Harvard provide additional valuable resources for trainees. In sum, in this renewal application, we have created a cohesive, integrated, high quality training program in basic, translational and clinical research i the pathogenesis and treatment of rheumatic diseases.

Public Health Relevance

Research Training in Rheumatology at the Massachusetts General Hospital is designed to prepare the next generations of research scientists who, through mentored research and rigorous training in new technologies, are prepared to be leaders in rheumatology related biomedical research. The overall goal of this program is to educate trainees so that they can contribute to our understanding of the immunopathogenesis of rheumatic diseases, and translate these findings to better clinical care for patients with these important diseases.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Arthritis and Musculoskeletal and Skin Diseases Special Grants Review Committee (AMS)
Program Officer
Mao, Su-Yau
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
Wallace, Zachary S; Mattoo, Hamid; Mahajan, Vinay S et al. (2016) Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford) 55:1000-8
Wallace, Zachary S; Lu, Na; Unizony, Sebastian et al. (2016) Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum 45:483-9
Schoenfeld, Sara R; Lu, Leo; Rai, Sharan K et al. (2016) Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 75:1315-20
Wallace, Zachary S; Lu, Na; Miloslavsky, Eli et al. (2016) Nationwide Trends in Hospitalizations and In-Hospital Mortality of Granulomatosis with Polyangiitis. Arthritis Care Res (Hoboken) :
Vodopivec, Ivana; Oakley, Derek H; Perugino, Cory A et al. (2016) A 44-year-old man with eye, kidney, and brain dysfunction. Ann Neurol 79:507-19
Schoenfeld, Sara R; Choi, Hyon K; Sayre, Eric C et al. (2016) Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study. Arthritis Care Res (Hoboken) 68:246-53
Mattoo, Hamid; Mahajan, Vinay S; Maehara, Takashi et al. (2016) Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol 138:825-38
Schoenfeld, Sara R; Castelino, Flavia V (2015) Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 41:237-48
Carruthers, Mollie N; Topazian, Mark D; Khosroshahi, Arezou et al. (2015) Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 74:1171-7
Lochhead, Robert B; Zachary, James F; Dalla Rosa, Luciana et al. (2015) Antagonistic Interplay between MicroRNA-155 and IL-10 during Lyme Carditis and Arthritis. PLoS One 10:e0135142

Showing the most recent 10 out of 49 publications